Paxil Birth Defects – International Coalition for Drug Awareness

Understanding Paxil Birth Defects

Ann Blake-Tracy14 years ago06 mins

In December 2005, GlaxoSmithKline (GSK) posted its Paxil findings on its
website regarding pregnant women taking antidepressants. In this announcement,
GSK noted that it was revising its pregnancy precaution category from C to D.
This revision was based on recent studies that indicated positive evidence of
human fetal risk. In addition, GSK was placing this information in the WARNINGS
section of the Paxil label.

The FDA then advised pregnant women to switch from Paxil to another SSRI
drug, such as Prozac or Zoloft. This warning was based on the results of an
analysis of Sweden’s birth registry that showed women who took Paxil were 1.5 to

Recent Cases Blog

PAXIL: BIRTH DEFECTS – TEST CASE FOR OVER 600 MORE CASES – USA

Ann Blake-Tracy15 years ago05 mins

GlaxoSmithKline P.L.C., the world’s second-biggest drugmaker, begins a trial in Philadelphia next week in what may be a test case for more than 600 lawsuits over claims that the company’s antidepressant drug Paxil causes birth defects.

Patients and their parents say internal company documents show Glaxo failed to warn consumers about the risks of Paxil until forced to do so in 2005 by the Food and Drug Administration. In the trial set to start Monday, Michelle David blames the drug for causing life-threatening heart defects in her son, Lyam Kilker, now age 3.

ICFDA on Drug Discontinuation: Dropping “cold turkey” off any medication, most especially mind altering medications, can often be MORE DANGEROUS than staying on the drugs.

Understanding Paxil Birth Defects

PAXIL: BIRTH DEFECTS – TEST CASE FOR OVER 600 MORE CASES – USA